ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Dietary Interventions Reduce Breast Cancer Risk In Trials

May 27, 2005

2015 Breakthrough Prize Winners Announced at Gala

November 14, 2014

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993